Digital pathology-based prognostic model for hepatocellular carcinoma: Integrating pathomics signatures with clinical parameters for recurrence prediction and biological interpretation
Computer Methods and Programs in Biomedicine · 2026-02 · 275 · 109180
DOI: 10.1016/j.cmpb.2025.109180 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Computer Methods and Programs in Biomedicine, 2026-02. Verfasst von Qi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Lin hai, Zhejiang, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hubei Technological Innovation Special Fund, Science and Technology Program of Zhejiang Province, Zhejiang University Student Science and Technology Innovation Activity Plan.
Abstract (Originalsprache)
BACKGROUND: Hepatocellular carcinoma (HCC) remains a therapeutic challenge due to high post-resection recurrence rates and heterogeneous outcomes. We developed and validated a digital pathology-based prognostic model combining pathomics signatures with clinical parameters to predict recurrence and elucidate biological mechanisms. METHODS: In this multicenter retrospective study, 294 HCC patients (training set: n = 198; validation set: n = 96) undergoing curative hepatectomy were analyzed. Pathomics features were quantitatively extracted from H&E-stained whole-slide images. Predictive modeling incorporated machine learning approaches (DT, KNN, LASSO, NB, RF, SVM) with clinical variables. Model performance was evaluated through ROC analysis, calibration, and decision curve analysis. Biological interpretation leveraged TCGA transcriptomic data analyzed via GSEA and WGCNA. RESULTS: Tumor and peri‑tumor pathomics parameters showed some complementarity in the prediction of HCC recurrence. The combined LASSO-based model showed the best predictive efficacy, with AUCs of 0.850 and 0.807 in the training and validation sets, respectively. The integrated pathomics-clinical model achieved AUCs of 0.893 and 0.860 in training and validation sets. Bioinformatics analysis suggested that the pathomics was correlated with the tumor immune microenvironment, as verified by multiple immunofluorescence staining of the validation set. CONCLUSION: This study establishes a robust digital pathology framework that not only improves HCC recurrence prediction beyond conventional biomarkers but also provides mechanistic insights into tumor-immune crosstalk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Lin hai, Zhejiang, China.
- Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- Department of Gastroenterology, The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China. Electronic address: 51467361@qq.com.
- Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: liulong6179@163.com.
- Department of Gastroenterology, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, Zhejiang, China; Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestiv…
Förderung
- Hubei Technological Innovation Special Fund
- Science and Technology Program of Zhejiang Province
- Zhejiang University Student Science and Technology Innovation Activity Plan
- Science and Technology Planning Project of Guangdong Province
- National Natural Science Foundation of China
- Zhejiang Key Laboratory of Pathophysiology
- Science and Technology Plan Project of Taizhou
- Department of Health of Zhejiang Province
Zitieren
APA
Wang, Q., Huang, Y., Zhang, Y., Zhu, Y., Hu, P., Xu, Y., Jiang, Z. Y., Liu, L., & Li, S. W. (2026). Digital pathology-based prognostic model for hepatocellular carcinoma: Integrating pathomics signatures with clinical parameters for recurrence prediction and biological interpretation. Computer Methods and Programs in Biomedicine, 275, 109180. https://doi.org/10.1016/j.cmpb.2025.109180
Vancouver
Wang Q, Huang Y, Zhang Y, Zhu Y, Hu P, Xu Y, et al. Digital pathology-based prognostic model for hepatocellular carcinoma: Integrating pathomics signatures with clinical parameters for recurrence prediction and biological interpretation. Computer Methods and Programs in Biomedicine. 2026;275:109180. doi:10.1016/j.cmpb.2025.109180
BibTeX
@article{Wang2026,
author = {Wang, Qi and Huang, Yuxi and Zhang, Yu and Zhu, Yu and Hu, Peng and Xu, Yongfu and Jiang, Zhen-Yu and Liu, Long and Li, Shao-Wei},
title = {Digital pathology-based prognostic model for hepatocellular carcinoma: Integrating pathomics signatures with clinical parameters for recurrence prediction and biological interpretation},
journal = {Computer Methods and Programs in Biomedicine},
year = {2026},
volume = {275},
pages = {109180},
doi = {10.1016/j.cmpb.2025.109180}
}
EUVIMED